1/6
07:00 am
mcrb
Seres Therapeutics Announces Publications in Nature Medicine and Journal of Infectious Diseases Highlighting Vowst™ Mechanism of Action and Supporting Broader Live Biotherapeutic Strategy
Low
Report
Seres Therapeutics Announces Publications in Nature Medicine and Journal of Infectious Diseases Highlighting Vowst™ Mechanism of Action and Supporting Broader Live Biotherapeutic Strategy
11/24
07:00 am
mcrb
Seres Therapeutics to Participate in Piper Sandler Healthcare Conference
Medium
Report
Seres Therapeutics to Participate in Piper Sandler Healthcare Conference
11/18
01:20 pm
mcrb
Seres Therapeutics (NASDAQ:MCRB) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
High
Report
Seres Therapeutics (NASDAQ:MCRB) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.